ANNA JONES: Open Payments
NPI 1902541659 · GASTONIA, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,923 in 85 payments from 21 companies in 2025. Trend: 2023 $166 · 2024 $755 · 2025 $1,923
Food & beverage: $1,846Education: $77
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 11 | $340 |
| Madrigal Pharmaceuticals | 7 | $215 |
| PFIZER INC. | 12 | $206 |
| ABBVIE INC. | 12 | $176 |
| Aimmune Therapeutics, Inc. | 7 | $175 |
| Intercept Pharmaceuticals, Inc. | 4 | $154 |
| Gilead Sciences, Inc. | 7 | $144 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $106 |
| Regeneron Healthcare Solutions, Inc. | 2 | $56 |
| Lilly USA, LLC | 3 | $48 |
Products named: TREMFYA, REZDIFFRA, ZENPEP, OCALIVA, XELJANZ, XIFAXAN, RINVOQ, DUPIXENT.
Industry payments across NC — which companies pay providers there.
